| 689508 |
FRONTIERS IN ONCOLOGY |
Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study |
2021-05-14 |
10.3389/fonc.2021.538927 |
Li Dong-Yang, Yang Fei, Liao Wei-Qiang, Zhou Xiang-Fu, Li Wen-Biao, Cai Jia-Rong, Liu Bo-Long, Luo Yun, Zhan Hai-Lun |
| 689507 |
FRONTIERS IN ONCOLOGY |
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines |
2021-05-14 |
10.3389/fonc.2021.663225 |
Biagioni Alessio, Chillà Anastasia, Del Rosso Mario, Fibbi Gabriella, Scavone Francesca, Andreucci Elena, Peppicelli Silvia, Bianchini Francesca, Calorini Lido, Li Santi Anna, Ragno Pia, Margheri Francesca, Laurenzana Anna |
| 689506 |
FRONTIERS IN ONCOLOGY |
Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy |
2021-05-14 |
10.3389/fonc.2021.694578 |
Malapelle Umberto, Leprieur Etienne Giroux, Kamga Paul Takam, Chiasseu Marius Tresor, Rolfo Christian |
| 689505 |
FRONTIERS IN ONCOLOGY |
Ultrasound-Guided Percutaneous Core Needle Biopsy of Peripheral Pulmonary Nodules ≤ 2 cm: Diagnostic Performance, Safety and Influence Factors |
2021-05-14 |
10.3389/fonc.2021.671884 |
Huang Weijun, Ye Jieyi, Qiu Yide, Peng Weiwei, Lan Ninghui, Huang Ting, Ou Yinghui, Deng Xiaoyun, Li Yingjia |
| 689504 |
FRONTIERS IN ONCOLOGY |
The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram |
2021-05-14 |
10.3389/fonc.2021.671811 |
He Qian, Li Longhao, Ren Qinglan |
| 689503 |
FRONTIERS IN ONCOLOGY |
A Comprehensive RNA Study to Identify circRNA and miRNA Biomarkers for Docetaxel Resistance in Breast Cancer |
2021-05-14 |
10.3389/fonc.2021.669270 |
Huang Peide, Li Fengyu, Mo Zongchao, Geng Chunyu, Wen Fang, Zhang Chunyan, Guo Jia, Wu Song, Li Lin, Brünner Nils, Stenvang Jan |
| 689502 |
FRONTIERS IN ONCOLOGY |
Evaluation of Cell Surface Vimentin Positive Circulating Tumor Cells as a Diagnostic Biomarker for Lung Cancer |
2021-05-14 |
10.3389/fonc.2021.672687 |
Xie Xiaohong, Wang Liqiang, Wang Xinni, Fan Wan-Hung, Qin Yinyin, Lin Xinqing, Xie Zhanhong, Liu Ming, Ouyang Ming, Li Shiyue, Zhou Chengzhi |
| 689501 |
FRONTIERS IN ONCOLOGY |
The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers |
2021-05-14 |
10.3389/fonc.2021.691199 |
Zhu Runzhi, Tu Yanjie, Chang Jingxia, Xu Haixia, Li Jean C., Liu Wang, Do Ahn-Dao, Zhang Yuxia, Wang Jinhu, Li Benyi |
| 689500 |
FRONTIERS IN ONCOLOGY |
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors |
2021-05-14 |
10.3389/fonc.2021.548243 |
Ghantasala Saicharan, Pai Medha Gayathri J., Biswas Deeptarup, Gahoi Nikita, Mukherjee Shuvolina, KP Manubhai, Nissa Mehar Un, Srivastava Alisha, Epari Sridhar, Shetty Prakash, Moiyadi Aliasgar, Srivastava Sanjeeva |
| 689499 |
FRONTIERS IN ONCOLOGY |
Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies |
2021-05-14 |
10.3389/fonc.2021.668162 |
Abbas Hussein A., Wierda William G. |
